Stay updated on Pembrolizumab for Mesothelioma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Mesothelioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Mesothelioma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added 'Results Submission Events (1)' and 'Revision: v3.5.2'; removed 'Revision: v3.5.0' from the history.
    Difference
    0.3%
    Check dated 2026-04-17T02:13:07.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Addition of 'Results Submitted' and removal of 'No Results Posted' are reflected in the study record history.
    Difference
    0.1%
    Check dated 2026-04-02T15:15:55.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T05:10:27.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    A new revision entry labeled v3.4.3 has been added to the Record History, and the previous v3.4.2 entry has been removed.
    Difference
    0.1%
    Check dated 2026-03-12T02:16:09.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the record history. Removed the funding-lapse notice and Revision: v3.4.1 from the history.
    Difference
    0.8%
    Check dated 2026-02-11T12:08:22.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    A government funding lapse notice was added at the top of the page. The revision history now includes Revision: v3.4.1, replacing v3.4.0.
    Difference
    0.8%
    Check dated 2026-02-04T06:48:17.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Mesothelioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Mesothelioma Clinical Trial page.